🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Virax Biolabs Group Ltd (VRAX)

NASDAQ
Currency in USD
2.0100
-0.0500(-2.43%)
Closed
After Hours
1.9600-0.0500(-2.4876%)
VRAX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
1.98002.0800
52 wk Range
0.60008.9999
Key Statistics
Edit
Prev. Close
2.06
Open
2.07
Day's Range
1.98-2.08
52 wk Range
0.6-8.9999
Volume
94,400
Average Volume (3m)
6,024,044
1-Year Change
-19.5%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VRAX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Virax Biolabs Group Ltd Company Profile

Virax Biolabs Group Limited, a biotechnology company, distributes, markets, and sells diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name. It also develops T-Cell IVD test kit for COVID-19, which intend to adapt for immunological profiling against multiple viral threats under the ViraxImmune Brand, as well as a proprietary mobile application for ViraxImmune that presents an individual’s immunological profiling data and provide advice on the users’ immune system. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, pharmaceutical companies, research institutions, hospital systems, and public and private institutions. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was founded in 2013 and is headquartered in Lanarkshire, the United Kingdom.

Compare VRAX to Peers and Sector

Metrics to compare
VRAX
Peers
Sector
Relationship
P/E Ratio
−1.3x−0.7x−0.6x
PEG Ratio
−0.04−0.020.00
Price/Book
1.6x0.7x2.6x
Price / LTM Sales
55.8x1.2x3.2x
Upside (Analyst Target)
-70.8%44.1%
Fair Value Upside
Unlock20.7%6.2%Unlock

People Also Watch

1.220
TVGN
+7.02%
2.810
HOLO
-6.64%
2.7500
BIVI
+3.77%
1.550
GNPX
-8.28%
1.080
DUO
-21.74%

FAQ

What Is the Virax Biolabs (VRAX) Stock Price Today?

The Virax Biolabs (VRAX) stock price today is 2.01.

What Stock Exchange Does Virax Biolabs Trade On?

Virax Biolabs is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Virax Biolabs?

The stock symbol for Virax Biolabs is "VRAX."

What Is the Virax Biolabs Market Cap?

As of today, Virax Biolabs market cap is 8.73M.

What is Virax Biolabs Earnings Per Share?

The Virax Biolabs EPS is -3.36.

From a Technical Analysis Perspective, Is VRAX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.